U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula O3
Molecular Weight 47.9982
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of OZONE

SMILES

[O-][O+]=O

InChI

InChIKey=CBENFWSGALASAD-UHFFFAOYSA-N
InChI=1S/O3/c1-3-2

HIDE SMILES / InChI

Molecular Formula O3
Molecular Weight 47.9982
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Ozone, a gas, is made by three oxygen atoms. It is used for different procedures. Ozone therapy is used to treat a wide range of diseases and seems to be particularly useful in the treatment of many chronic diseases. It acts via the controlled oxidative stress that promotes an up-regulation of the antioxidant system and a modulation of the immune system. Ozone therapy doesn’t have any side effect and was useful in fibromyalgia management, where the employed therapies are very often ineffective. Ozone therapy is also going to be studied in phase III clinical trials to standard management of patients with advanced ischemic heart disease. Besides, ozone therapy was studying for the treatment of chronic hepatitis B.

Approval Year

PubMed

PubMed

TitleDatePubMed
NAD(P)H quinone oxidoreductase 1 is essential for ozone-induced oxidative stress in mice and humans.
2009-07
Ozone stress down-regulates the expression of cystic fibrosis transmembrane conductance regulator in human bronchial epithelial cells.
2009-05-15
Age, strain, and gender as factors for increased sensitivity of the mouse lung to inhaled ozone.
2009-02
Role of metallothionein in lung inflammation induced by ozone exposure in mice.
2008-12-15
Role of p38 mitogen-activated protein kinase in ozone-induced airway hyperresponsiveness and inflammation.
2008-12-14
Ozone exposure, antioxidant genes, and lung function in an elderly cohort: VA normative aging study.
2008-11
Environmental public health tracking of childhood asthma using California health interview survey, traffic, and outdoor air pollution data.
2008-09
Modulation of ozone-induced airway hyperresponsiveness and inflammation by interleukin-13.
2008-09
Lung inflammation and thrombogenic responses in a time course study of Csb mice exposed to ozone.
2008-08
Air pollution, airway inflammation, and lung function in a cohort study of Mexico City schoolchildren.
2008-06
Ozone inhalation induces exacerbation of eosinophilic airway inflammation and hyperresponsiveness in allergen-sensitized mice.
2008-04
Regulation of caveolin-1 expression, nitric oxide production and tissue injury by tumor necrosis factor-alpha following ozone inhalation.
2008-03-15
Is there an association between lifetime cumulative exposure and acute pulmonary responses to ozone?
2008-03
Associations of FcepsilonRIbeta E237G polymorphism with wheezing in Taiwanese schoolchildren.
2008-03
Air pollution and postneonatal infant mortality in the United States, 1999-2002.
2008-01
Integrated disinfection by-products (DBP) mixtures research: gene expression alterations in primary rat hepatocyte cultures exposed to DBP mixtures formed by chlorination and ozonation/postchlorination.
2008
Protective role of matrix metalloproteinase-9 in ozone-induced airway inflammation.
2007-11
Ozone enhancement of lower airway allergic inflammation is prevented by gamma-tocopherol.
2007-10-15
Comparative assessment of air pollution-related health risks in Houston.
2007-10
Air pollution alters brain and pituitary endothelin-1 and inducible nitric oxide synthase gene expression.
2007-10
Effects of antioxidant enzyme polymorphisms on ozone-induced lung function changes.
2007-10
Role of TLR2, TLR4, and MyD88 in murine ozone-induced airway hyperresponsiveness and neutrophilia.
2007-10
Type I interleukin-1 receptor is required for pulmonary responses to subacute ozone exposure in mice.
2007-10
PPARalpha and AP-2alpha regulate bombesin receptor subtype 3 expression in ozone-stressed bronchial epithelial cells.
2007-07-01
Attenuation of ozone-induced airway inflammation and hyper-responsiveness by c-Jun NH2 terminal kinase inhibitor SP600125.
2007-07
Role of surfactant protein-A (SP-A) in lung injury in response to acute ozone exposure of SP-A deficient mice.
2007-04-01
Parental smoking modifies the relation between genetic variation in tumor necrosis factor-alpha (TNF) and childhood asthma.
2007-04
Atmospheric photochemical transformations enhance 1,3-butadiene-induced inflammatory responses in human epithelial cells: The role of ozone and other photochemical degradation products.
2007-03-20
Ozone induces clear cellular and molecular responses in the mouse lung independently of the transcription-coupled repair status.
2007-03
Lung injury after ozone exposure is iron dependent.
2007-01
Ozonation of human blood induces a remarkable upregulation of heme oxygenase-1 and heat stress protein-70.
2007
Upregulation of substance P receptor expression by calcitonin gene-related peptide, a possible cooperative action of two neuropeptides involved in airway inflammation.
2007
GSTM1 and GSTP1 and respiratory health in asthmatic children exposed to ozone.
2006-11
Postnatal lung development: immediate-early gene responses post ozone and LPS exposure.
2006-10
Wound repair and proliferation of bronchial epithelial cells enhanced by bombesin receptor subtype 3 activation.
2006-07
Ozone induces oxidative stress in rat alveolar type II and type I-like cells.
2006-06-01
Pulmonary expression of preproET-1 and preproET-3 mRNAs is altered reciprocally in rats after inhalation of air pollutants.
2006-06
Elevation of susceptibility to ozone-induced acute tracheobronchial injury in transgenic mice deficient in Clara cell secretory protein.
2006-05-15
Associations of tumor necrosis factor G-308A with childhood asthma and wheezing.
2006-05-01
Increased pulmonary responses to acute ozone exposure in obese db/db mice.
2006-05
Efficiency of tazobactam/piperacillin in lethal peritonitis is enhanced after preconditioning of rats with O3/O2-pneumoperitoneum.
2006-01
Augmented responses to ozone in obese carboxypeptidase E-deficient mice.
2006-01
Ozone enhances diesel exhaust particles (DEP)-induced interleukin-8 (IL-8) gene expression in human airway epithelial cells through activation of nuclear factors- kappaB (NF-kappaB) and IL-6 (NF-IL6).
2005-12
The association between fatal coronary heart disease and ambient particulate air pollution: Are females at greater risk?
2005-12
Acute ozone-induced differential gene expression profiles in rat lung.
2005-12
Differential regulation of the lung endothelin system by urban particulate matter and ozone.
2005-11
Systemic responses to inhaled ozone in mice: cachexia and down-regulation of liver xenobiotic metabolizing genes.
2005-10-15
Relation between ambient air quality and selected birth defects, seven county study, Texas, 1997-2000.
2005-08-01
Molecular analysis of hprt mutation in B6C3F1 mice exposed to ozone alone and combined treatment of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone and/or dibutyl phthalate for 32 and 52 weeks.
2004-12
Inactivation of human immunodeficiency virus type 1 by ozone in vitro.
1991-10-01
Patents

Sample Use Guides

patients with fibromyalgia: autohemotransfusion in 55 patients and by ozone rectal insufflations in 10 patients, according to SIOOT (Scientific Society of Oxygen Ozone Therapy) protocols, twice a week for one month and then twice a month as maintenance therapy.
Route of Administration: Rectal
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:36:56 GMT 2025
Edited
by admin
on Mon Mar 31 18:36:56 GMT 2025
Record UNII
66H7ZZK23N
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
OZONE [FCC]
Preferred Name English
OZONE
FCC   HSDB   INCI   MI   WHO-DD  
INCI  
Official Name English
TRIATOMIC OXYGEN
Common Name English
Ozone [WHO-DD]
Common Name English
OZONE [HSDB]
Common Name English
OZONE [MI]
Common Name English
Classification Tree Code System Code
CFR 21 CFR 173.368
Created by admin on Mon Mar 31 18:36:56 GMT 2025 , Edited by admin on Mon Mar 31 18:36:56 GMT 2025
CFR 21 CFR 184.1563
Created by admin on Mon Mar 31 18:36:56 GMT 2025 , Edited by admin on Mon Mar 31 18:36:56 GMT 2025
Code System Code Type Description
HSDB
717
Created by admin on Mon Mar 31 18:36:56 GMT 2025 , Edited by admin on Mon Mar 31 18:36:56 GMT 2025
PRIMARY
PUBCHEM
24823
Created by admin on Mon Mar 31 18:36:56 GMT 2025 , Edited by admin on Mon Mar 31 18:36:56 GMT 2025
PRIMARY
EPA CompTox
DTXSID0021098
Created by admin on Mon Mar 31 18:36:56 GMT 2025 , Edited by admin on Mon Mar 31 18:36:56 GMT 2025
PRIMARY
RXCUI
2289011
Created by admin on Mon Mar 31 18:36:56 GMT 2025 , Edited by admin on Mon Mar 31 18:36:56 GMT 2025
PRIMARY
MERCK INDEX
m8350
Created by admin on Mon Mar 31 18:36:56 GMT 2025 , Edited by admin on Mon Mar 31 18:36:56 GMT 2025
PRIMARY Merck Index
FDA UNII
66H7ZZK23N
Created by admin on Mon Mar 31 18:36:56 GMT 2025 , Edited by admin on Mon Mar 31 18:36:56 GMT 2025
PRIMARY
CAS
10028-15-6
Created by admin on Mon Mar 31 18:36:56 GMT 2025 , Edited by admin on Mon Mar 31 18:36:56 GMT 2025
PRIMARY
MESH
D010126
Created by admin on Mon Mar 31 18:36:56 GMT 2025 , Edited by admin on Mon Mar 31 18:36:56 GMT 2025
PRIMARY
ECHA (EC/EINECS)
233-069-2
Created by admin on Mon Mar 31 18:36:56 GMT 2025 , Edited by admin on Mon Mar 31 18:36:56 GMT 2025
PRIMARY
CHEBI
25812
Created by admin on Mon Mar 31 18:36:56 GMT 2025 , Edited by admin on Mon Mar 31 18:36:56 GMT 2025
PRIMARY
DAILYMED
66H7ZZK23N
Created by admin on Mon Mar 31 18:36:56 GMT 2025 , Edited by admin on Mon Mar 31 18:36:56 GMT 2025
PRIMARY
EVMPD
SUB33402
Created by admin on Mon Mar 31 18:36:56 GMT 2025 , Edited by admin on Mon Mar 31 18:36:56 GMT 2025
PRIMARY
SMS_ID
100000126056
Created by admin on Mon Mar 31 18:36:56 GMT 2025 , Edited by admin on Mon Mar 31 18:36:56 GMT 2025
PRIMARY
WIKIPEDIA
OZONE
Created by admin on Mon Mar 31 18:36:56 GMT 2025 , Edited by admin on Mon Mar 31 18:36:56 GMT 2025
PRIMARY
DRUG BANK
DB12510
Created by admin on Mon Mar 31 18:36:56 GMT 2025 , Edited by admin on Mon Mar 31 18:36:56 GMT 2025
PRIMARY
Related Record Type Details
ACTIVE MOIETY